This week’s Medicare updates include the End Stage Renal Disease Prospective Payment System final rule, an update to home health provisions in the Benefit Policy Manual to implement elements of the CARES Act, an OIG report on device credits, and more!
Q: For the purposes of determining a Medicare overpayment, should claims that we are uncertain whether they were appropriate be included? Is this defined under the False Claims Act (FCA)?
This week’s Medicare updates include a new interim final rule on COVID-19 vaccination and payment policies, Part II of the CY 2022 Medicare Advantage and Part D Advance Notice, a proposed rule on DMEPOS coverage policies and fee schedule methodologies, and more!
The discovery of an overpayment raises serious questions about compliance requirements. Understand your organization’s reporting obligation and appropriate methods for determining overpayments.
This week’s Medicare updates include the latest edition of the Medicare Quarterly Provider Compliance Newsletter, two new proposed decision memos on coverage for blood-based biomarker tests and a molecular expression test, updated information in the COVID-19 billing FAQs, and more!
